Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/07/2023 | AN2 Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 23.7k | $5.91 | $140.3k | | 06/07/2023 |
02/03/2023 | Cyteir Therapeutics, Inc. | CYT | Grant | Stock Option (Right to Buy) | 14.2k | $1.69 | $23.9k | | 02/03/2023 |
12/07/2022 | Cyteir Therapeutics, Inc. | CYT | Purchase | Common Stock | 21.2k | $1.30 | $27.6k | | 12/07/2022 |
05/12/2022 | Cyteir Therapeutics, Inc. | CYT | Purchase | Common Stock | 743 | $1.61 | $1.2k | | 05/12/2022 |
05/12/2022 | AN2 Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 10.4k | $17.28 | $179.1k | | 05/12/2022 |
05/11/2022 | Cyteir Therapeutics, Inc. | CYT | Purchase | Common Stock | 1000 | $1.70 | $1.7k | | 05/10/2022 |
05/10/2022 | Cyteir Therapeutics, Inc. | CYT | Purchase | Common Stock | 49.4k | $1.89 | $93.4k | | 05/10/2022 |
03/29/2022 | AN2 Therapeutics, Inc. | | Conversion | Common Stock | 98.2k | $0.00 | $0 | | 03/29/2022 |
03/29/2022 | AN2 Therapeutics, Inc. | | Conversion | Series A Convertible Preferred Stock | 98.2k | $0.00 | $0 | | 03/29/2022 |
02/25/2022 | SANGAMO THERAPEUTICS, INC | SGMO | Grant | Common Stock | 12.5k | $0.00 | $0 | | 02/25/2022 |
02/25/2022 | SANGAMO THERAPEUTICS, INC | SGMO | Grant | Stock Option (Right to Buy) | 25k | $5.90 | $147.5k | | 02/25/2022 |
02/22/2022 | Cyteir Therapeutics, Inc. | CYT | Grant | Stock Option (Right to Buy) | 14.2k | $5.96 | $84.3k | | 02/22/2022 |
12/28/2021 | Cyteir Therapeutics, Inc. | CYT | Purchase | Common Stock | 601 | $9.85 | $5.9k | | 12/23/2021 |
12/27/2021 | Cyteir Therapeutics, Inc. | CYT | Purchase | Common Stock | 200 | $9.97 | $2k | | 12/23/2021 |
12/27/2021 | Cyteir Therapeutics, Inc. | CYT | Purchase | Common Stock | 99 | $10.18 | $1k | | 12/23/2021 |
12/23/2021 | Cyteir Therapeutics, Inc. | CYT | Purchase | Common Stock | 200 | $9.87 | $2k | | 12/23/2021 |
12/17/2021 | Cyteir Therapeutics, Inc. | CYT | Purchase | Common Stock | 200 | $9.88 | $2k | | 12/17/2021 |
12/15/2021 | Cyteir Therapeutics, Inc. | CYT | Purchase | Common Stock | 2k | $10.47 | $20.9k | | 12/15/2021 |
12/15/2021 | Cyteir Therapeutics, Inc. | CYT | Purchase | Common Stock | 1.7k | $11.12 | $18.9k | | 12/15/2021 |
12/15/2021 | AMARIN CORP PLC\UK | AMRN | Purchase | | 2k | $3.16 | $6.3k | | 12/14/2021 |
12/14/2021 | AMARIN CORP PLC\UK | AMRN | Purchase | | 10k | $3.27 | $32.7k | | 12/14/2021 |
11/19/2021 | ACCELERON PHARMA INC | XLRN | Disposition | Option to Purchase Common Stock | 10k | $41.20 | $412k | | 11/19/2021 |
11/19/2021 | ACCELERON PHARMA INC | XLRN | Disposition | Option to Purchase Common Stock | 7.5k | $41.64 | $312.3k | | 11/19/2021 |
11/19/2021 | ACCELERON PHARMA INC | XLRN | Disposition | Option to Purchase Common Stock | 8.2k | $52.99 | $433.7k | | 11/19/2021 |
11/19/2021 | ACCELERON PHARMA INC | XLRN | Disposition | Option to Purchase Common Stock | 3.2k | $115.53 | $372.2k | | 11/19/2021 |
11/19/2021 | ACCELERON PHARMA INC | XLRN | Other | Common Stock | 34.5k | $0.00 | $0 | | 11/19/2021 |
11/19/2021 | ACCELERON PHARMA INC | XLRN | Disposition | Option to Purchase Common Stock | 10k | $27.97 | $279.7k | | 11/19/2021 |
11/19/2021 | ACCELERON PHARMA INC | XLRN | Disposition | Option to Purchase Common Stock | 7.5k | $30.17 | $226.3k | | 11/19/2021 |
11/19/2021 | ACCELERON PHARMA INC | XLRN | Disposition | Option to Purchase Common Stock | 7.5k | $40.61 | $304.6k | | 11/19/2021 |
06/22/2021 | Cyteir Therapeutics, Inc. | CYT | Conversion | Common Stock | 58.7k | $0.00 | $0 | See Footnote | 06/22/2021 |
06/22/2021 | Cyteir Therapeutics, Inc. | CYT | Conversion | Series B Convertible Preferred Stock | 200k | $0.00 | $0 | See Footnote | 06/22/2021 |
06/14/2021 | AMARIN CORP PLC\UK | AMRN | Grant | Stock Option (Right to Buy) | 46k | $5.00 | $229.8k | | 06/14/2021 |
06/14/2021 | AMARIN CORP PLC\UK | AMRN | Grant | | 36k | $0.00 | $0 | | 06/14/2021 |
04/05/2021 | ACCELERON PHARMA INC | XLRN | Sale | Common Stock | 2.2k | $141.28 | $304k | | 04/05/2021 |
04/05/2021 | ACCELERON PHARMA INC | XLRN | Sale | Common Stock | 1.1k | $142.27 | $156.5k | | 04/05/2021 |
|